Tenax Therapeutics (TENX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 04-2014 | 01-2014 | 10-2013 | 07-2013 | 04-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | -9,128 | -5,777 | -2,245 | N/A |
| Depreciation Amortization | N/A | 111 | 75 | 37 | N/A |
| Accounts receivable | N/A | 370 | 616 | 679 | N/A |
| Other Working Capital | N/A | -758 | -67 | -31 | N/A |
| Other Operating Activity | 0 | 3,123 | 1,577 | -3 | 0 |
| Operating Cash Flow | $N/A | $-6,282 | $-3,576 | $-1,563 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -10 | N/A | N/A | N/A |
| Purchase Sale Intangibles | N/A | -103 | -69 | -33 | N/A |
| Other Investing Activity | 0 | -103 | -69 | -33 | 0 |
| Investing Cash Flow | $N/A | $-113 | $-69 | $-33 | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 141 | N/A | N/A | N/A |
| Common Stock Issued | N/A | 7,003 | 567 | N/A | N/A |
| Other Financing Activity | 0 | 4,807 | 4,838 | 4,886 | 0 |
| Financing Cash Flow | $N/A | $11,951 | $5,405 | $4,886 | $N/A |
| Beginning Cash Position | N/A | 784 | 784 | 784 | N/A |
| End Cash Position | N/A | 6,340 | 2,543 | 4,073 | N/A |
| Net Cash Flow | $N/A | $5,556 | $1,759 | $3,290 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | -6,282 | -3,576 | -1,563 | N/A |
| Capital Expenditure | N/A | -10 | N/A | N/A | N/A |
| Free Cash Flow | 0 | -6,292 | -3,576 | -1,563 | 0 |